Investment
Features
FeesSafety
Academy
More
Pluang+

BellRing Brands faces shareholder lawsuit over alleged sales misrepresentation tied to inventory stockpiling.

Market News
18 Aug 2026
Newsfile Corp
View Source
Bearish
pluang ai news

Kuehn Law is investigating BellRing Brands' officers and directors for allegedly misleading shareholders by attributing strong sales to end-consumer demand, while sales were actually boosted by temporary inventory stockpiling by key customers. This misrepresentation concealed the company's declining market share amid rising competition. Shareholders who bought BellRing stock before November 19, 2024, are encouraged to contact the law firm to explore legal options. This case highlights risks in corporate disclosures and could impact investor confidence in BellRing.

More News

Grocery Outlet posts Q2 revenue growth and beats EPS forecasts amid strategic restructuring.

Grocery Outlet posts Q2 revenue growth and beats EPS forecasts amid strategic restructuring.

Grocery Outlet Holding Corp. reported a 1.1% revenue increase to $1.19 billion in Q2 2026 and an adjusted EPS of $0.20, beating analyst expectations despite a 13% EPS decline. The company is undergoing strategic restructuring, including closing 36 un...

Company Fundamentals
Bullish
29 minutes ago
Hesai posts revenue beat and 60% net income growth despite EPS miss in Q2 2026

Hesai posts revenue beat and 60% net income growth despite EPS miss in Q2 2026

Hesai Group reported Q2 2026 earnings with revenue of $126.9 million, slightly above expectations, driven by strong LiDAR sales. Despite an EPS of $0.01 missing the $0.08 estimate, the company achieved its fifth consecutive GAAP profitable quarter, w...

Company Fundamentals
Bullish
33 minutes ago
Amylyx Pharma shares jump 54% on positive Phase 3 trial for avexitide reducing hypoglycemia.

Amylyx Pharma shares jump 54% on positive Phase 3 trial for avexitide reducing hypoglycemia.

Amylyx Pharmaceuticals' stock surged 54.43% after its drug avexitide showed positive Phase 3 trial results, cutting hypoglycemic events by 55% in post-bariatric patients. UBS set a $45 price target, implying a 36% upside from current levels. The stoc...

Market News
Bullish
2 hours ago
Ondas boosts growth with Aran Defense acquisition and strong Q2 revenue, raising 2026 outlook.

Ondas boosts growth with Aran Defense acquisition and strong Q2 revenue, raising 2026 outlook.

Ondas is expanding its market and technology through acquiring Aran Defense Ltd., enhancing its autonomous and defense systems. The company reported record Q2 revenue of $83.8 million, up 67% from the previous quarter and over 13 times year-over-year...

Company Fundamentals
Bullish
2 hours ago
Xiaomi beats revenue and EPS estimates but net profit drops amid rising costs and weak demand

Xiaomi beats revenue and EPS estimates but net profit drops amid rising costs and weak demand

Xiaomi Corp reported better-than-expected earnings per share of $0.05 and revenue of $16.04 billion, surpassing analyst forecasts. However, the company faces significant margin pressure from rising component costs and weaker consumer demand, causing ...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App